Literature DB >> 29528191

Thyroid cancer in adolescents and young adults.

Maura Massimino1, Douglas B Evans2, Marta Podda1, Claudio Spinelli3, Paola Collini4, Natalia Pizzi5, Archie Bleyer6.   

Abstract

In adolescents and young adults, thyroid cancer accounts for 13% of all invasive neoplasms, being three times more frequent in females, but overdiagnosis and overtreatment are common. There are two therapeutic approaches, one radical and no longer preferred in all instances, and the other conservative. Permanent complications of surgery and metabolic irradiation can affect quality of life and carry an economic burden. The overall survival rate approaches 100% for patients with differentiated thyroid cancer regardless of the extent of treatment. Medullary thyroid carcinoma is a very different entity, occurring most frequently in the context of hereditary tumor susceptibility syndromes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  adolescents; overdiagnosis; thyroid cancer; young adults

Mesh:

Year:  2018        PMID: 29528191     DOI: 10.1002/pbc.27025

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  13 in total

1.  Independent risk factors and feasibility of ultrasound diagnosis of ultrasound-guided non-cytologically diagnostic thyroid nodules.

Authors:  Cheng Jiang; Jiandong Chang; Xiaoyan Chen; Hao Zhang; Meina Xu
Journal:  Gland Surg       Date:  2021-09

2.  Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway.

Authors:  Qun-Guang Jiang; Cheng-Feng Xiong; Yun-Xia Lv
Journal:  Mol Cell Biochem       Date:  2020-11-17       Impact factor: 3.396

Review 3.  Imaging and Imaging-Based Management of Pediatric Thyroid Nodules.

Authors:  Ioannis Iakovou; Evanthia Giannoula; Christos Sachpekidis
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

4.  Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.

Authors:  Paola Solis-Pazmino; Jorge Salazar-Vega; Eddy Lincango-Naranjo; Cristhian Garcia; Gabriela Jaramillo Koupermann; Esteban Ortiz-Prado; Tannya Ledesma; Tatiana Rojas; Benjamin Alvarado-Mafla; Cesar Carcamo; Oscar J Ponce; Juan P Brito
Journal:  BMC Cancer       Date:  2021-01-08       Impact factor: 4.430

5.  lncRNA RUNDC3A-AS1 Regulates Proliferation and Apoptosis of Thyroid Cancer Cells via the miR-151b/SNRPB Axis.

Authors:  Yan Deng; Jie Wu; Xin Li
Journal:  Int J Endocrinol       Date:  2022-02-22       Impact factor: 3.257

Review 6.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

7.  Thyroid surgery in children and young adults: potential overtreatment and complications.

Authors:  Julia I Staubitz; Julia Bode; Alicia Poplawski; Felix Watzka; Joachim Pohlenz; Hauke Lang; Thomas J Musholt
Journal:  Langenbecks Arch Surg       Date:  2020-05-27       Impact factor: 3.445

8.  Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.

Authors:  Suping Xin; Xinhua Ye
Journal:  Int J Mol Med       Date:  2020-10-19       Impact factor: 4.101

Review 9.  CircRNA: A novel potential strategy to treat thyroid cancer (Review).

Authors:  Guomao Zhu; Xingyu Chang; Yuchen Kang; Xinzhu Zhao; Xulei Tang; Chengxu Ma; Songbo Fu
Journal:  Int J Mol Med       Date:  2021-09-16       Impact factor: 4.101

10.  BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.

Authors:  Yubing Tao; Fei Wang; Xiaopei Shen; Guangwu Zhu; Rengyun Liu; David Viola; Rossella Elisei; Efisio Puxeddu; Laura Fugazzola; Carla Colombo; Barbara Jarzab; Agnieszka Czarniecka; Alfred K Lam; Caterina Mian; Federica Vianello; Linwah Yip; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Christine J O'Neill; Mark S Sywak; Roderick Clifton-Bligh; Bela Bendlova; Vlasta Sýkorová; Shihua Zhao; Yangang Wang; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.